Tutorials › Response-Adaptive Randomization › Regression To The Mean In Adaptive Trials

Comparison With Fixed Randomization · Tutorial 87 of 501

Regression To The Mean In Adaptive Trials

Learn how early random variation and adaptive selection can make a treatment arm look better than its underlying response, and how to interpret the later movement toward less extreme estimates.

Intermediate 10 min read

What You'll Learn

  • Distinguish regression to the mean from a real change in treatment effectiveness.
  • Derive the expected later estimate under a simple normal model.
  • Explain why choosing an arm based on favorable early outcomes tends to select positive noise.
  • Calculate how an early binary response rate can change as more patients are observed.
  • Identify assumptions and warning signs when interpreting an arm’s changing results.
  • Compare adaptive allocation with fixed randomization as a source of selection of early extremes.

Why an Early Lead May Narrow

In a response-adaptive trial, outcomes observed so far can influence which treatment receives the next allocation. This creates a practical temptation: if one arm has a high early response rate, it may seem that the treatment is especially effective and deserves more patients. But an early estimate combines the arm’s underlying response with random variation. If that variation happens to be favorable, later outcomes will usually be less favorable than the early record—not because the treatment has changed, but because the unusually favorable fluctuation is unlikely to persist at the same size.

This pattern is called regression to the mean. It matters in adaptive trials because an allocation rule may preferentially send more patients to the arm that currently looks best. The rule can therefore select an arm partly for having a favorable random fluctuation. The selected arm may continue to perform well, particularly if its underlying response really is higher, while still looking less exceptional as additional outcomes arrive.

Definition: Regression to the mean is the tendency for an outcome or estimate that is unusually far from its long-run or relevant reference value to be followed, on average, by an outcome or estimate closer to that reference value. It is a statement about expected movement under a specified model, not a guarantee that every later observation will be less extreme.

Two ideas are essential. First, an arm’s early estimate is uncertain. Second, an allocation rule that favors the highest early estimate preferentially selects positive noise along with any real treatment advantage. Regression to the mean does not mean that the treatment’s true efficacy declines, that an adaptive rule must choose the wrong arm, or that every later estimate must be closer to the truth.

A Model for Early and Later Estimates

For a transparent derivation, suppose candidate treatment arms have true mean outcomes \(\theta\), measured in a specified unit. Across arms, represent these means as draws from a distribution centered at \(\mu\), with variance \(\tau^2\). For one arm, let its early estimate be \(Y_0=\theta+\varepsilon_0\), where the estimation error has mean zero and variance \(s_0^2\). Suppose a later estimate is \(Y_1=\theta+\varepsilon_1\), with mean-zero error independent of the early error given \(\theta\). Use a normal model for this derivation: \(\theta\sim N(\mu,\tau^2)\), and \(\varepsilon_0\sim N(0,s_0^2)\), \(\varepsilon_1\sim N(0,s_1^2)\). These assumptions describe stable arm means, unbiased estimates, and independent early and later sampling errors conditional on the true arm mean.

Because the early estimate equals the true mean plus its error, observing \(Y_0=y\) gives information about both. The conditional expected true mean is a weighted average of the overall center and the early estimate. The later estimate has the same conditional expectation, because its new error has conditional mean zero.

$$ E(Y_1\mid Y_0=y) =E(\theta\mid Y_0=y) =\mu+\frac{\tau^2}{\tau^2+s_0^2}(y-\mu). $$

The multiplier \(\rho=\tau^2/(\tau^2+s_0^2)\) lies between zero and one when \(\tau^2>0\) and \(s_0^2>0\). Thus, if \(y\) is above \(\mu\), the conditional expected later estimate is above \(\mu\), but not as far above as \(y\); the corresponding statement holds for an estimate below \(\mu\). When early estimates are noisy relative to differences between true arm means, \(s_0^2\) is large compared with \(\tau^2\), so the expected movement toward \(\mu\) is greater. This is a conditional expectation, not a prediction that the next estimate must move in that direction.

Worked Examples

Worked Example: Shrinkage of an Early Continuous-Outcome Estimate

Suppose the mean outcome across a group of candidate arms is \(\mu=50\) points, and the variance of true arm means is \(\tau^2=16\) points squared. An early estimate for one arm is \(y=62\) points, with estimation-error variance \(s_0^2=36\) points squared. Under the normal model above, find the expected later estimate.

The reliability multiplier is \( \rho=16/(16+36)=16/52=0.3077 \). Therefore,

$$ E(Y_1\mid Y_0=62) =50+\frac{16}{52}(62-50) =50+0.3077(12) =53.69\text{ points}. $$

The early estimate is 12 points above the center, while its conditional expected later estimate is about 3.69 points above the center. This does not say the arm’s true mean is known to be 53.69 points, nor does it say the later estimate will equal 53.69. It describes the model-based average over possible true means and later sampling errors, conditional on the early estimate.

Worked Example: An Early Binary Response Rate

Suppose an arm has a stable response probability \(p=0.60\), and each patient’s binary response is independent with that probability. In a hypothetical trial, 9 of the first 10 patients assigned to the arm respond, giving an early rate of \(9/10=0.90\). If 20 more patients are assigned to the same arm, what response rate is expected across all 30 patients?

The expected number of responses among the next 20 patients is \(20(0.60)=12\). Adding the 9 already observed gives an expected total of \(9+12=21\) responses. Hence the expected final rate, conditional on the first 10 outcomes and the assumed stable probability, is

$$ \frac{9+20(0.60)}{30} =\frac{21}{30} =0.70. $$

The rate is expected to move from 0.90 to 0.70, still above the true response probability of 0.60 because the nine early responses remain in the cumulative total. The rate is not expected to become exactly 0.60 after only 20 additional patients. The calculation assumes independent patient outcomes and a response probability that remains 0.60 for patients assigned to this arm.

Worked Example: Selecting the Higher of Two Early Estimates

Consider two treatments with the same true mean outcome, 50 points. Suppose each early estimate is normally distributed around its treatment mean with standard error 10 points, independently across arms. An adaptive rule assigns more patients to whichever arm has the higher early estimate. How much higher than 50 points is the selected early estimate expected to be, solely because it is the larger of two noisy estimates?

Write the early estimates as \(Y_1=50+\varepsilon_1\) and \(Y_2=50+\varepsilon_2\), where the errors are independent \(N(0,10^2)\). The larger error has expectation \(E[\max(\varepsilon_1,\varepsilon_2)]=\tfrac12 E[|\varepsilon_1-\varepsilon_2|]\). The difference is normal with mean zero and standard deviation \(\sqrt{10^2+10^2}=14.14\) points. For a mean-zero normal variable with standard deviation \(a\), the expected absolute value is \(a\sqrt{2/\pi}\). Therefore,

$$ E[\max(Y_1,Y_2)] =50+\frac{1}{2}(14.14)\sqrt{\frac{2}{\pi}} \approx 50+5.642 =55.64\text{ points}. $$

Under these assumptions, the arm selected for its higher early estimate is expected to start about 5.64 points above the common true mean, even though neither treatment is better. If new, independent patients are observed on the selected arm, their average outcome has expected value 50 points, conditional on the early data and the selection. The early selected estimate is therefore expected to look less exceptional in comparison with new outcomes. This calculation isolates selection of the larger of two estimates; it does not imply that every adaptive allocation rule selects exactly one arm or uses this particular rule.

Why Adaptation Can Amplify the Pattern

Regression to the mean can occur even when allocation is fixed: a noisy early estimate can be followed by a less extreme estimate regardless of how later patients are assigned. Adaptation adds a selection mechanism. When early outcomes influence allocation, arms with unusually favorable early estimates are more likely to receive additional patients. If the arms’ true effects are similar, favorable noise can help determine which arm gets selected for greater exposure.

The selected arm’s later results should be interpreted as new evidence, not as confirmation that the early rate was its stable response. Conversely, a later decline does not by itself show that the adaptive rule failed or that the treatment has become less effective. The early and later estimates answer related but different questions: one summarizes a small initial sample, while the other includes additional patients or uses new observations.

A useful way to separate the two sources of an early lead is to ask how much of it could plausibly be sampling error. The normal-model multiplier above makes this idea explicit when its assumptions are reasonable: a noisy early estimate receives less weight in predicting the arm’s underlying mean. In a binary-outcome setting, the uncertainty in a small-sample response rate can likewise be substantial. A rate of 8/10 is less precise than a rate of 80/100, even though both equal 0.80.

Assumptions, Diagnostics, and Alternatives

The simple calculations rely on assumptions that may not hold in a trial. The continuous-outcome derivation assumes a stable true mean for each arm, a suitable normal model, and independent early and later estimation errors conditional on that mean. The binary example assumes a stable response probability and independent outcomes. If outcome definitions, patient mix, follow-up, or treatment delivery change over time, the later rate can differ for reasons other than random regression to the mean. A model of regression to the mean does not explain every observed change.

Useful diagnostics include checking the number of early observations and the uncertainty around the early estimate; comparing early and later outcomes rather than relying only on a cumulative rate; and asking whether the allocation rule directly uses the outcomes being interpreted. A striking early estimate based on few observations, followed by allocation that favors that estimate, is a particular reason for caution. Also check for changes in who is enrolled or how outcomes are measured. A decline after the early period is consistent with regression to the mean, but it is not proof of it.

Fixed randomization is a useful comparison. It does not eliminate random early extremes or their tendency to be followed by less extreme observations. However, when allocation is fixed independently of observed responses, it does not preferentially assign more patients to the arm with the best observed early result. Response-adaptive allocation can use accumulating information to alter assignments, but that same feedback makes it especially important not to treat an early leader as though its estimate were precise or permanently representative. Neither approach guarantees that the arm with the highest observed rate has the highest true response.

Common pitfall: “The arm’s early response rate was 0.90, so its true response probability is 0.90; if the later rate falls, the treatment must have become less effective.” This reasoning treats a noisy early estimate as the true probability and mistakes expected movement toward a less extreme value for a treatment change. The correction is to distinguish the observed rate from the underlying response probability, consider the early sample size and model assumptions, and allow for ordinary sampling variation.

Regression to the mean is a limitation on how confidently an early lead should be interpreted, not a reason to disregard early outcomes altogether. An early result can contain information about a real difference as well as noise. The normal-model derivation shows the balance: the expected later estimate remains related to the early estimate, but is pulled toward the center when the early estimate is uncertain. If true treatment effects are very different or early estimates are precise, that pull may be modest. If the estimate is noisy and the arms are similar, an early lead may be much less informative than its raw size suggests.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. In the normal model, if \(y>\mu\), why is the expected later estimate between \(\mu\) and \(y\), assuming positive \(\tau^2\) and \(s_0^2\)?
  2. An arm has 7 responses among 10 patients. Assume its stable response probability is 0.50 and 10 additional patients are assigned. What is the expected cumulative response rate after all 20 patients?
  3. Does regression to the mean imply that an adaptive allocation rule caused a treatment’s efficacy to decrease? Explain.
  4. Give two reasons, other than random regression to the mean, that an arm’s response rate might differ between early and later patients.

Solutions. (1) The conditional expectation is \(\mu+\rho(y-\mu)\), where \(\rho=\tau^2/(\tau^2+s_0^2)\) is strictly between zero and one. It is therefore above \(\mu\) and less than \(y\). (2) The expected number of later responses is \(10(0.50)=5\), so the expected cumulative rate is \((7+5)/20=12/20=0.60\). (3) No. Regression to the mean describes expected movement in estimates or outcomes under a model; it does not imply that the treatment’s true efficacy changed. (4) Examples include a change in the types of patients enrolled, a change in outcome measurement or follow-up, and a change in treatment delivery. Such changes violate or alter assumptions used in the simple regression-to-the-mean calculations.

Clinical Biostats